NAC Rollout With Life-Critical Medical Devices
A hospital network is deploying 802.1X network access control to 6,000 managed endpoints and 400 medical devices across five campuses. The pilot on two floors showed that 12% of devices fail supplicant authentication, including infusion pumps and a legacy nurse-call gateway. A failed authentication places the device in a remediation VLAN that cannot reach the clinical application. The vendor confirms the nurse-call gateway firmware is end-of-support and will not receive a supplicant. The rollout is scheduled for all campuses in three weeks. Clinical engineering requires zero unplanned downtime for life-critical devices. The project has a rollback plan that requires manually moving 40 switches back to monitor mode, estimated at four hours. The chief information officer wants a go/no-go recommendation.
1. What is your go/no-go recommendation for the enterprise rollout, and why?
Read the worked answer
The recommendation should be no-go for the full rollout in three weeks. The pilot failure rate is not acceptable for life-critical devices, and the remediation VLAN design turns an authentication failure into a clinical availability incident. The nurse-call gateway cannot be fixed by firmware, and the four-hour rollback is too slow for a life-safety environment. A go decision would depend on evidence that no life-critical device can be isolated and that rollback is faster than the clinical impact threshold.
A conditional path is to proceed in waves: non-clinical endpoints first, then medical devices by class, with life-critical devices excluded until exceptions and compensating controls are validated. The team should complete a device inventory with model, firmware, supplicant support, and clinical criticality. Each exception needs a documented compensating control and clinical engineering approval.
The chief information officer should receive the residual risk and the schedule impact. The security engineer should not approve a rollout that relies on clinical staff discovering failures. If leadership overrides, the decision should be recorded as a risk acceptance with explicit acceptance of clinical downtime risk, which clinical engineering may not be authorized to accept.
2. How should legacy and non-supplicant devices be handled? What compensating controls are appropriate?
Read the worked answer
The devices should be handled through a formal exception process, not a blanket whitelist. For each device, document the business and clinical need, the reason it cannot support 802.1X, its network requirements, and the proposed control. A MAC authentication bypass can be used only with profiling and a restricted VLAN, because MAC addresses can be spoofed. The device VLAN should permit only the specific clinical application and management endpoints, deny lateral traffic, and be monitored.
Compensating controls include network segmentation, static IP reservations, port security, anomaly detection on the device VLAN, and a documented replacement plan for end-of-support firmware. The nurse-call gateway should be treated as a high-priority replacement because it is both life-critical and unsupported. If the vendor cannot provide a secure path, the clinical engineering and security teams should accept the risk jointly with a dated mitigation plan.
The exception register should be reviewed periodically and should expire. The goal is to avoid both extremes: forcing unsupported devices into a failing authentication state, and permanently exempting them from all controls. Each exception should state what risk is accepted and what would trigger removal.
3. What operational metrics and rollback triggers should govern the phased rollout?
Read the worked answer
Metrics should measure both security and clinical outcomes: authentication success rate by device class, number of devices in the remediation VLAN, time to remediate failed authentication, help-desk ticket volume, and any clinical application unavailable or degraded. The team should also track exception counts, unauthorized device attempts, and switch configuration drift. A daily review during each wave allows fast correction.
Rollback triggers should be defined before the wave starts. Examples: any life-critical device isolated for more than 15 minutes; more than two clinical applications degraded in a campus; authentication failure rate above an agreed threshold for a device class; or rollback testing showing the four-hour estimate is optimistic. The rollback procedure should be tested and, if possible, automated or reduced to a single command per switch group. Four hours is too slow for life-safety; the team should invest in a faster fallback before proceeding.
The go/no-go for each wave should use these metrics and triggers, with clinical engineering and the chief information officer as decision makers. The security engineer should document the results, update the exception register, and feed lessons into the next wave. This turns the rollout into a controlled engineering process rather than a single high-risk event.